The 73,000-square-foot buildings will house 96 beds each. Geisinger and Acadia will invest $80 million to build them.
One facility will be built in Moosic, Pa., and open in 2022. The other will be built in Danville and will open in 2023.
“This joint venture was a natural fit based on a shared commitment to identifying behavioral health needs in the community and partnering to bring world-class care close to home for everyone who needs it in central and northeastern Pennsylvania,” said Jaewon Ryu, MD, Geisinger’s president and CEO.
Geisinger said it will consolidate inpatient behavioral health services from Geisinger Medical Center in Danville, Geisinger Bloomsburg (Pa.) Hospital and Geisinger Community Medical Center in Scranton, Pa., in the new facilities, allowing vacated space to be repurposed for other patient care needs.
More articles on healthcare industry transactions:
Biggest local health systems not interested in buying Tower Health
Union warns against HCA’s purchase of rural Georgia hospital
Keck Medicine, Methodist Hospital explore affiliation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
